Mast Therapeutics Company Profile (NYSEMKT:MSTX)

About Mast Therapeutics

Mast Therapeutics logoMast Therapeutics, Inc. is a biopharmaceutical company. The Company develops clinical-stage therapies for serious or life-threatening diseases with unmet needs. The Company focuses on developing new therapies for sickle cell disease, a chronic and genetic disorder classified as a rare, or orphan, disease in the United States of America and European Union, and for heart failure, a condition with an unmet need for treatment options. The Company's segment is engaged in the business of developing therapies for serious or life-threatening diseases. The Company focuses on its Molecular Adhesion and Sealant Technology (MAST) platform, to develop MST-188 (vepoloxamer) Injection, its lead product candidate. The Company also develops AIR001, a sodium nitrite solution for intermittent inhalation through nebulizer. The Company's AIR001 is in Phase II clinical development for the treatment of patients with HFpEF.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: MSTX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.13
  • 50 Day Moving Average: $0.4406
  • 200 Day Moving Average: $0.3741
  • 52-Week Range: $211,815,000.00 - $0.10
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.55
  • P/E Growth: 0.0000
  • Market Cap: $26.99M
  • Outstanding Shares: 211,815,000
  • Beta: 1.16
Additional Links:
Companies Related to Mast Therapeutics:

Analyst Ratings

Consensus Ratings for Mast Therapeutics (NYSEMKT:MSTX) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.67

Analysts' Ratings History for Mast Therapeutics (NYSEMKT:MSTX)
Show:
DateFirmActionRatingPrice TargetDetails
5/25/2016Maxim GroupReiterated RatingBuy$5.00View Rating Details
2/2/2016Canaccord GenuityReiterated RatingBuy$3.00View Rating Details
10/12/2015Cowen and CompanyReiterated RatingBuyView Rating Details
10/8/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Mast Therapeutics (NYSEMKT:MSTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/6/2016Q116($0.06)($0.06)ViewN/AView Earnings Details
3/14/2016Q415($0.06)($0.06)ViewN/AView Earnings Details
11/12/2015Q315($0.06)($0.06)ViewListenView Earnings Details
8/12/2015($0.04)($0.06)ViewN/AView Earnings Details
8/12/2015Q215($0.04)($0.06)ViewListenView Earnings Details
5/11/2015Q1($0.06)($0.06)ViewN/AView Earnings Details
3/24/2015Q414($0.06)($0.05)ViewN/AView Earnings Details
10/31/2014Q314($0.06)($0.06)ViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)ViewN/AView Earnings Details
5/5/2014Q114($0.07)($0.06)ViewN/AView Earnings Details
3/26/2014($0.07)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mast Therapeutics (NYSEMKT:MSTX)
Current Year EPS Consensus Estimate: $-0.2100 EPS
Next Year EPS Consensus Estimate: $-0.0500 EPS

Dividends

Dividend History for Mast Therapeutics (NYSEMKT:MSTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mast Therapeutics (NYSEMKT:MSTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/27/2015Brandi RobertsCFOBuy38,000$0.50$19,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mast Therapeutics (NYSEMKT:MSTX)
DateHeadline
investopedia.com logoMast Therapeutics Crash Led By Poor Results (MSTX) (NYSEMKT:MSTX)
www.investopedia.com - September 21 at 5:56 PM
News IconPenny Stock Investors Take an Interest in Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NYSEMKT:MSTX)
www.duncanindependent.com - September 21 at 10:23 AM
News IconBiotech news that matter for investors: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Clovis Oncology, Inc. (NASDAQ:CLVS) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - September 21 at 10:23 AM
smarteranalyst.com logoStock Update (NYSEMKT:MSTX): Here's Why Mast Therapeutics Inc Shares Crashed 84% - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - September 21 at 10:23 AM
feeds.benzinga.com logoShkreli Warned You: Mast Therapeutics Plummets 80% After Sickle Cell Drug Phase 3 Trial Fail (NYSEMKT:MSTX)
feeds.benzinga.com - September 20 at 5:57 PM
News IconUnder the Microscope: Getting a Closer Look at Shares of Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NYSEMKT:MSTX)
www.duncanindependent.com - September 19 at 6:15 PM
News IconBiotech news that matter for investors: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - September 19 at 6:15 PM
News IconSizzling Stock Alert - Mast Therapeutics, Inc.'s (MSTX) - Hot Stocks Point (NYSEMKT:MSTX)
www.hotstockspoint.com - September 19 at 10:46 AM
4-traders.com logoMast Therapeutics : Joins New Sickle Cell Disease Coalition, Supports Campaign To Improve Treatment And Care (NYSEMKT:MSTX)
www.4-traders.com - September 17 at 10:46 AM
News IconTime To Put On The Watch List? - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Mast Therapeutics, Inc. (NYSEMKT ... - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - September 16 at 9:46 AM
prnewswire.com logoResearch Reports on Biotech Equities -- Galena Biopharma, Mast Therapeutics, Medivation, and Amgen - PR Newswire (press release) (NYSEMKT:MSTX)
www.prnewswire.com - September 16 at 9:46 AM
News IconKeen Investors Narrowing Their Focus on Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NYSEMKT:MSTX)
www.duncanindependent.com - September 15 at 9:40 AM
marketexclusive.com logoWhy The Mast Therapeutics Inc (NYSEMKT:MSTX) Dip Might Be An Opportunity - Market Exclusive (NYSEMKT:MSTX)
marketexclusive.com - September 15 at 9:40 AM
News IconAnalyst's Review on: Mast Therapeutics Inc (NYSEMKT:MSTX) - Post Registrar (NYSEMKT:MSTX)
postregistrar.com - September 15 at 9:40 AM
marketexclusive.com logoWhy The Mast Therapeutics Inc (NYSEMKT:MSTX) Dip Might Be An Opportunity (NYSEMKT:MSTX)
marketexclusive.com - September 14 at 6:21 PM
News IconWhy The Mast Therapeutics Inc (MSTX) Dip Might Be An Opportunity (NYSEMKT:MSTX)
feedproxy.google.com - September 14 at 1:55 PM
benzinga.com logoShkreli Thinks Jazz Pharmaceuticals Is Worth $20 Billion, While ... - Benzinga (NYSEMKT:MSTX)
www.benzinga.com - September 13 at 11:05 AM
News IconGetting a Closer Look at Shares of Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NYSEMKT:MSTX)
www.duncanindependent.com - September 12 at 6:00 PM
smarteranalyst.com logoMaxim's Take on Mast Therapeutics Inc (MSTX) Following 5th ... - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - September 12 at 6:00 PM
News IconTrader's Round Up – Mast Therapeutics, Inc.'s (MSTX) - Hot Stocks ... - Hot Stocks Point (NYSEMKT:MSTX)
www.hotstockspoint.com - September 12 at 10:54 AM
investopedia.com logoStrategic Coalition Is Good for Mast Therapeutics (MSTX) - Investopedia (NYSEMKT:MSTX)
www.investopedia.com - September 12 at 10:54 AM
News IconMaking News: Targeting shares of Mast Therapeutics, Inc. (:MSTX) - Duncan Research (NYSEMKT:MSTX)
www.duncanindependent.com - September 9 at 5:58 PM
News IconGrowth Analysis of Mast Therapeutics, Inc. (AMEX:MSTX) (NYSEMKT:MSTX)
10thousandcouples.com - September 9 at 10:56 AM
smarteranalyst.com logoMaxim Dives in on Mast Therapeutics Inc (MSTX) Following Recent ... - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - September 8 at 6:01 PM
News IconMast Therapeutics Inc (NYSEMKT:MSTX): A Catalyst Driven Momentum Stock (NYSEMKT:MSTX)
streetregister.com - September 8 at 10:04 AM
biz.yahoo.com logoMAST THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSEMKT:MSTX)
biz.yahoo.com - September 7 at 9:48 AM
streetinsider.com logoMast Therapeutics (MSTX) Announces Joining Sickle Cell Disease Coalition (NYSEMKT:MSTX)
www.streetinsider.com - September 6 at 10:57 AM
publicnow.com logoMast Therapeutics Joins New Sickle Cell Disease Coalition, Supports Campaign To Improve Treatment And Care (NYSEMKT:MSTX)
www.publicnow.com - September 6 at 10:57 AM
News IconMast Therapeutics (MSTX) Stock: The Full Story You Need To Know - CNA Finance (press release) (NYSEMKT:MSTX)
cnafinance.com - September 5 at 5:36 PM
News IconNoteworthy Stocks Activity: Mast Therapeutics Inc (NYSEMKT:MSTX), Cliffs Natural Resources Inc (NYSE:CLF) - Post Registrar (NYSEMKT:MSTX)
postregistrar.com - September 5 at 5:36 PM
News IconShares of Mast Therapeutics Inc (NYSEMKT:MSTX) & Liberty Interactive Group (NASDAQ:QVCA) Stocks News Update: Thursday (NYSEMKT:MSTX)
www.newsismoney.com - September 2 at 11:04 AM
News IconQuarterly Financial Watch for Mast Therapeutics, Inc. (AMEX:MSTX) - Newburg Press (NYSEMKT:MSTX)
newburghpress.com - August 31 at 11:11 AM
News IconBiotech Stocks Worth a Closer Look: Neuralstem, Inc. (NASDAQ:CUR), Mast Therapeutics, Inc. (NYSEMKT:MSTX) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - August 31 at 11:11 AM
News IconHC Trending Hot Stocks: Bristol-Myers Squibb Co (BMY), Mast Therapeutics Inc (MSTX) - share market updates (press release) (NYSEMKT:MSTX)
sharemarketupdates.com - August 25 at 11:25 AM
News IconBiotech news that matter for investors: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Intrexon Corporation (NYSE:XON) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - August 23 at 6:29 PM
istreetwire.com logoStocks Roundup: ONEOK Inc. (OKE), Mast Therapeutics, Inc. (MSTX), The Wendy's Company (WEN) - iStreetWire (NYSEMKT:MSTX)
istreetwire.com - August 23 at 10:43 AM
News IconMSTX April 2017 Options Begin Trading (NYSEMKT:MSTX)
www.stockoptionschannel.com - August 22 at 6:18 PM
finance.yahoo.com logoMAST THERAPEUTICS, INC. Financials (NYSEMKT:MSTX)
finance.yahoo.com - August 19 at 6:13 PM
News IconBiotechnology Stocks in Limelight: Novavax, Inc. (NASDAQ:NVAX), Mast Therapeutics Inc (NYSEMKT:MSTX) - Post Registrar (NYSEMKT:MSTX)
postregistrar.com - August 16 at 6:26 PM
News IconMix Momentum Detain Active Stocks- Mast Therapeutics (NYSE ... - Seneca Globe (NYSEMKT:MSTX)
www.senecaglobe.com - August 10 at 6:43 PM
News IconNews review of 2 biotech stocks: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Clovis Oncology, Inc. (NASDAQ:CLVS) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - August 10 at 6:43 PM
News IconHC Stocks Updates: UnitedHealth Group Inc (UNH), Mast Therapeutics Inc (MSTX) - share market updates (press release) (NYSEMKT:MSTX)
sharemarketupdates.com - August 10 at 6:43 PM
News IconTrading the Biotech News: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Amicus Therapeutics, Inc. (NASDAQ:FOLD) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - August 9 at 6:33 PM
streetupdates.com logoAnalyst Rating Trends to Observe: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) , Mast Therapeutics, Inc ... - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - August 9 at 9:28 AM
publicnow.com logoMast Therapeutics Awarded Small Business Innovation Research Grant From The National Institutes Of Health (NYSEMKT:MSTX)
www.publicnow.com - August 8 at 10:58 AM
finance.yahoo.com logo8:09 am Mast Therapeutics receives a Small Business Innovation Research grant from the NIH (NYSEMKT:MSTX)
finance.yahoo.com - August 8 at 10:58 AM
News IconAnalyst Stock Ratings: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Enbridge Energy Partners, L.P. (NYSE:EEP) - TWN (NYSEMKT:MSTX)
thewellesleysnews.com - August 6 at 9:08 AM
News IconWorth Watching Stock's Buzzers: Mast Therapeutics Inc (NYSEMKT:MSTX), Cummins Inc.(NYSE:CMI) - NYSE Journal (press release) (NYSEMKT:MSTX)
stockznews.com - August 4 at 6:41 PM
smarteranalyst.com logoRoth Capital Bullish on Mast Therapeutics Inc (MSTX) Following Successful Phase II Results for AIR001 - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - August 4 at 9:29 AM
News IconMast Therapeutics Inc (NYSEMKT:MSTX): Here's What We're ... - Insider Financial (NYSEMKT:MSTX)
www.insiderfinancial.com - August 4 at 9:28 AM

Social


Last Updated on 9/25/2016 by MarketBeat.com Staff